FIBROBLAST GROWTH FACTOR RECEPTOR 2

Approval Year

Substance Class	Protein Created by `admin` on `Tue Apr 01 16:36:37 GMT 2025` Edited by `admin` on `Tue Apr 01 16:36:37 GMT 2025`
Protein Sub Type
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	S344CKA15F
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

FIBROBLAST GROWTH FACTOR RECEPTOR 2

Common Name

English

FGFR-2

Preferred Name

English

FGFR2

Common Name

English

KERATINOCYTE GROWTH FACTOR RECEPTOR

Common Name

English

Code System Code Type Description

PHAROS

P21802

Created by admin on Tue Apr 01 16:36:37 GMT 2025 , Edited by admin on Tue Apr 01 16:36:37 GMT 2025

PRIMARY

FDA UNII

S344CKA15F

Created by admin on Tue Apr 01 16:36:37 GMT 2025 , Edited by admin on Tue Apr 01 16:36:37 GMT 2025

PRIMARY

UNIPROT

P21802

Created by admin on Tue Apr 01 16:36:37 GMT 2025 , Edited by admin on Tue Apr 01 16:36:37 GMT 2025

PRIMARY

From	To
1_41	1_86
1_158	1_210
1_257	1_321

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_62
N	1_102
N	1_207
N	1_220
N	1_244
N	1_276
N	1_297
N	1_310

Related Record Type Details


					GK8781218Z

APRUTUMAB

INHIBITOR -> TARGET


					RJ5NUR6485

Fibroblast growth factor receptor 2 (V564I)

MUTANT->PARENT

Amount:


					Y7HJ4D4CRT

ODM-203

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					CEGM9YBNGD

Selpercatinib

INHIBITOR -> TARGET

Comments:

at higher concentrations that were still clinically achievable


					2167OG1EKJ

Fexagratinib

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					890E37NHMV

ERDAFITINIB

INHIBITOR -> TARGET

Amount:


					LQX7RFK8MZ

ALOFANIB

INHIBITOR -> TARGET


					DDD2AB5TWK

APRUTUMAB IXADOTIN

INHIBITOR -> TARGET


					N9B0H171MJ

DERAZANTINIB

INHIBITOR -> TARGET


					Y6BX7BL23K

PEMIGATINIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					G6HRD2P839

Nintedanib

INHIBITOR -> TARGET


					E9M363811V

LY-2874455

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					ID912S5VON

MIDOSTAURIN

INHIBITOR -> TARGET


					PP449XA4BH

LUCITANIB

INHIBITOR -> TARGET

Amount:


					98BSN6N516

ROGARATINIB

INHIBITOR -> TARGET

Amount:


					DDD2AB5TWK

APRUTUMAB IXADOTIN

CONJUGATED TOXIN->TARGET


					TN7CUD1NGA

TASURGRATINIB

INHIBITOR -> TARGET

Amount:


					NR9ZYH80Z8

ZOLIGRATINIB

INHIBITOR -> TARGET

Amount:


					S3OPE9IA3Q

PRN-1371

INHIBITOR -> TARGET


					A4055ME1VK

INFIGRATINIB

INHIBITOR -> TARGET


					RJW23BQ0KW

BEMARITUZUMAB

INHIBITOR -> TARGET


					4B93MGE4AL

FUTIBATINIB

INHIBITOR -> TARGET

Amount:

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO ACID SUBSTITUTION	[1_445] [1_565] [1_567] [1_635] [1_636] [1_748]				TYROSINE O-PHOSPHATE	2R86C98KDX
AMINO ACID SUBSTITUTION	[1_759]				DEXFOSFOSERINE	VI4F0K069V

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL